LS CancerDiag qualifies for the Catapult semifinals!

LS CancerDiag qualifies for the Catapult semifinals!

Congratulations to Niklas for qualifying LS CancerDiag to the EIT Health Catapult semifinals!

Introducing a unique competition and training programme that showcases biotech, medtech and digital health start-ups to leading experts and investors across Europe. The programme recognises and awards the very best business concepts, fast-tracking start-ups to become part of the EIT Health Community of world-leading companies.

LS CancerDiag participated in the regional pitch competition an was selected as only one of the six start-up from the Nordic countries going through to the semifinals!

The 42 start-ups chosen for the Semi-finals will now enter intense training days, during which they will be teamed up with mentors. The mentors review and potentially optimise the company business plan, and provide thorough pitch training, in order to improve the start-up’s ability to perform a funding roadshow in front of top-level seed or A-series investors.

After the training, semi-finalists will pitch in front of an international, high-profile jury and an audience of experienced corporate representatives, experts and investors. The top companies in the three categories of biotech, medtech and digital health – 21 start-ups in total – will be selected and invited to pitch during the finals at the EIT Health Summit. They will go head-to-head for their share of the €210,000 investment prize fund with the Audience Award Winner displayed on the New York Nasdaq Tower.

Watch the Semi-finals online

The EIT Health Catapult is inviting investors and experts to attend the virtual Semi-finals, from 1-3 December 2021, for the pitches and for matchmaking. These events provide the opportunity to make early contacts with the healthcare leaders of tomorrow. LS CancerDiag will be pitching on the second day and part of the Medtech category.

Dates for the public pitch days of the semi-finals are:

  • Biotech: 1 December 2021
  • Medtech: 2 December 2021
  • Digital Health: 3 December 2021


Find out more and register for the Semi-final events here.

Our participation in Catapult is already the fifth EIT Health support programmes that the company has been fortunate to be part of, such as Bridgehead Global, Bridgehead Europe, the Bootcamp, and the Investor Network . You can also find the announcement and the complete list of selected companies on the EIT Health news website.

About EIT Health

EIT Health is a network of best-in-class health innovators with approximately 150 partners and is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union. We collaborate across borders to deliver new solutions that can enable European citizens to live longer, healthier lives.

As Europeans tackle the challenge of increasing chronic diseases and multi-morbidity, and seek to realise the opportunities that technology offers to move beyond conventional approaches to treatment, prevention and healthy lifestyles, we need thought leaders, innovators and efficient ways to bring innovative healthcare solutions to market.

EIT Health addresses these needs. We connect all relevant healthcare players across European borders – making sure to include all sides of the “knowledge triangle”, so that innovation can happen at the intersection of research, education and business for the benefit of citizens.

EIT Health: Together for healthy lives in Europe.

For more information visit:

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.